3751 - 3760 of 7877 Results
Title
Year
-
OPENTitle: Analysis of heterozygous PRKN variants and copy number variations in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e28End Page: e28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.123Best OA location URL: https://doi.org/10.1101/2020.05.07.20072728Citation Count: 7
- Application of the ‘5-2-1’ screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBE2020OPENTitle: Application of the ‘5-2-1’ screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBEJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 10Issue #: 5Start Page: 309End Page: 323Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/nmt-2020-0021Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/nmt-2020-0021Citation Count: 40
-
RESTRICTEDTitle: Approach to Cognitive Impairment in Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1495End Page: 1510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00963-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00963-x.pdfCitation Count: 38
- Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned2020RESTRICTEDTitle: Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons LearnedJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1393End Page: 1405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00964-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00964-w.pdfCitation Count: 20
- Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers2020OPENTitle: Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000010863Best OA location URL: https://n.neurology.org/content/neurology/95/24/e3428.full.pdfCitation Count: 45
-
OPENTitle: BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1785End Page: 1795Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1007/s13311-020-00965-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00965-9.pdfCitation Count: 15
-
OPENTitle: Body-first versus brain-first biological subtyping of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 10Start Page: 2871End Page: 2873Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa293Best OA location URL: https://academic.oup.com/brain/article-pdf/143/10/2871/35939469/awaa293.pdfCitation Count: 17
- Characteristics, treatment patterns and disease burden of people with Parkinson's disease in the Parkinson's disease real-world impact assessment (PRISM) study2020RESTRICTEDTitle: Characteristics, treatment patterns and disease burden of people with Parkinson's disease in the Parkinson's disease real-world impact assessment (PRISM) studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e86End Page: e86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.312Citation Count: 0
- Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease2020OPENTitle: Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 171End Page: 177Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28319Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28319Citation Count: 3
- Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis2020RESTRICTEDTitle: Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and CannabisJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1434End Page: 1455Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00900-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00900-y.pdfCitation Count: 49